Jane Huang

Researcher Next ID · RN-021652

Researcher · Medicine

Edmonton, Qatar

Not currently recruitingFunding unknown

Research interests

Medicine

Chronic Lymphocytic Leukemia Research

Lymphoma Diagnosis and Treatment

Chronic Myeloid Leukemia Treatments

CAR-T cell therapy research

Viral-associated cancers and disorders

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(22)00293-5
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study
Blood · 2020 · https://doi.org/10.1182/blood.2020006844
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Blood · 2019 · https://doi.org/10.1182/blood.2019001160
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1509981
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2008.19.8721

No projects listed.